SCHEMBL23867473

SCHEMBL23867473

COc1ccc2[nH]cc(CC(=O)Nc3ccc(Nc4cc(C)nc(N5CCCC5)n4)cc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 2/20 0.53
▸ HCRTR2 O43614 2/20 0.53
▸ HTR1A P08908 3/20 0.52
▸ GALR2 O43603 3/20 0.51
▸ SLC2A1 P11166 1/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ TAAR1 Q96RJ0 1/20 0.50
▸ MTNR1A P48039 2/20 0.49
▸ MTNR1B P49286 2/20 0.49
▸ GALR1 P47211 2/20 0.48
▸ CCNE1 P24864 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.46
▸ MCHR1 Q99705 1/20 0.45
▸ HPGD P15428 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867468 0.89 HRH3 (0.45) HCRTR1HCRTR2SLC2A1CCNE1CDK2
SCHEMBL23867470 0.88 HRH3 (0.44) HCRTR1HCRTR2SLC2A1CCNE1CDK2
SCHEMBL23867472 0.88 HRH3 (0.48) HCRTR1HCRTR2SLC2A1CCNE1CDK2
SCHEMBL30234700 0.83 HRH3 (0.47) HTR1ASLC2A1CCNE1CDK2KDM4E
SCHEMBL23867524 0.81 HCRTR1 (0.52) HCRTR1HCRTR2SLC2A1MAPK1TAAR1
SCHEMBL30979651 0.80 SLC2A1 (0.51) HCRTR1HCRTR2HTR1ASLC2A1MAPK1
SCHEMBL31094227 0.79 SLC2A1 (0.44) SLC2A1CCNE1CDK2KDM4EMCHR1
SCHEMBL31094238 0.75 SLC2A1 (0.50) GALR2SLC2A1MAPK1TAAR1GALR1
SCHEMBL23859943 0.75 HRH3 (0.53) GALR2GALR1CCNE1CDK2KDM4E
SCHEMBL30165658 0.75 HRH3 (0.53) GALR2GALR1CCNE1CDK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback